OpenVSafe by OpenVAERS
Search V-safe

6FC-11282-30374

2 vaccinations 5 coded responses 21 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
604 / IL
Registered
2021-03-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-20
    Dose 1 — Moderna
  2. 2021-03-21
    Registered in v-safe
  3. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  7. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-27
    Health check-in — day 7, dose 1
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-04-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-10
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-17
    Dose 2 — Moderna
  13. 2021-04-17
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-04-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dysgeusia, Taste disorder — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness
    Free text: Change in taste: not gone, just altered. Some foods taste weird now.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Unevaluable event — Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Get care from a doctor or other healthcare professional
    Free text: Pizza delivery
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-23
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-04-26
    Health check-in — day 7, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  19. 2021-05-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-29
    Survey response — day 42, dose 2
    MedDRA: Anxiety, Panic attack — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: TIA brought on most likely by severe anxiety/ panic attack
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-29
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-07-18
    Survey response — 3 months, dose 2
    MedDRA: Anxiety, Depression, Facial paralysis, Office visit, Panic attack — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: Panic attacks and debilitating anxiety and depression; Bells palsy-like symptoms · Healthcare visit (other): in person follow ups
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-07-18
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  26. 2021-07-28
  27. 2021-10-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-04-18
    Survey response — 12 months, dose 2
    MedDRA: Arthritis, Pre-existing disease, Psoriasis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Before getting my second dose, my plaque psoriasis was at 99.5% remission. Since then, it has flared to about 20% coverage. Joint inflammation (knee, elbow, finger) is now also a problem when it hadn't been previously.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-20Moderna
22021-04-17Moderna

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-22

Systemic reaction (other): Change in taste: not gone, just altered. Some foods taste weird now.

2021-04-23

Healthcare visit (other): Pizza delivery

Release 8 — day 42, dose 2

2021-05-29

Symptoms: TIA brought on most likely by severe anxiety/ panic attack

Release 9 — 3 months, dose 2

2021-07-18

Symptoms: Panic attacks and debilitating anxiety and depression; Bells palsy-like symptoms
Healthcare visit (other): in person follow ups

Release 11 — 12 months, dose 2

2022-04-18

Symptoms: Before getting my second dose, my plaque psoriasis was at 99.5% remission. Since then, it has flared to about 20% coverage. Joint inflammation (knee, elbow, finger) is now also a problem when it hadn't been previously.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOUnevaluable event ✓ ✓ ✓
SDAnxiety ✓ ✓ ✓
SDArthritis · · ✓
SDDepression · · ✓
SDFacial paralysis · · ✓
SDPanic attack ✓ ✓ ✓
SDPre-existing disease · · ✓
SDPsoriasis · · ✓
SRODysgeusia ✓ ✓ ✓
SROTaste disorder ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release